EUVIMEDEUVIMED entdecken
Crossref

From simple body mass index to lifesaving action: Linking low muscle mass, late diagnosis, and survival in chemoradiotherapy-treated esophageal cancer

Sara Cristina González, Carmen Aida Ramirez, Esther Holgado, Felipe Couñago

World Journal of Clinical Oncology · 24.06.2026 · 17 (6)

DOI: 10.5306/wjco.119908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 24.06.2026. Verfasst von Sara Cristina González und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the challenging landscape of esophageal squamous cell carcinoma (ESCC), where late diagnosis often brings progressive dysphagia, feeding difficulties, and chronic caloric-protein deficits that accelerate muscle wasting even before treatment begins, Xiao et al offer a compelling insight in the World Journal of Clinical Oncology . Their retrospective analysis of 360 patients undergoing definitive chemoradiotherapy reveals that baseline body mass index (BMI) is a powerful, readily available predictor of low muscle mass (LMM). Each additional BMI unit is linked to roughly a 39% lower odds of LMM (odds ratio: 0.613; 95%CI: 0.531-0.707), with a clear inflection point around 21.5 kg/m2 marking heightened risk below this threshold. What truly stands out is the synergistic prognostic impact: Patients burdened by both low BMI and LMM face the bleakest outlook, with a median overall survival of only 17 months. This underscores that LMM is far more than a nutritional byproduct — it acts as an independent driver of poorer treatment tolerance, heightened toxicities, and reduced survival in locally advanced ESCC. These observations open a practical window for action in everyday oncology practice. A simple BMI measurement at diagnosis can serve as an immediate, zero-cost alert to prompt detailed body composition evaluation (ideally via pretreatment computed tomography) and swift multidisciplinary intervention. Early nutritional reinforcement — through hypercaloric, high-protein oral nutritional supplements (ONS) delivering ≥ 1.5-2.0 g protein/kg ideal body weight daily — has been shown in dedicated trials to preserve weight, BMI, albumin, and prealbumin levels while attenuating radiation esophagitis, myelosuppression, and other toxicities during radiotherapy or chemoradiotherapy in ESCC patients. Meta-analyses further support that high-protein ONS reduces complications and aids lean mass maintenance in high-sarcopenia-risk cancers such as esophageal cancer. When oral intake falters due to tumor-related dysphagia, enteral routes become essential, complemented by individualized dietitian guidance and frequent reassessments. Adding supervised resistance training (2-3 sessions/week) where performance status allows provides a vital non-nutritional countermeasure against sarcopenia progression. By viewing BMI and LMM not merely as prognostic signals but as modifiable targets, we can shift toward more proactive, personalized supportive care — potentially transforming outcomes in one of oncology’s most demanding diseases.

Zitieren

APA

González, S. C., Ramirez, C. A., Holgado, E., & Couñago, F. (2026). From simple body mass index to lifesaving action: Linking low muscle mass, late diagnosis, and survival in chemoradiotherapy-treated esophageal cancer. World Journal of Clinical Oncology, 17(6). https://doi.org/10.5306/wjco.119908

Vancouver

González SC, Ramirez CA, Holgado E, Couñago F. From simple body mass index to lifesaving action: Linking low muscle mass, late diagnosis, and survival in chemoradiotherapy-treated esophageal cancer. World Journal of Clinical Oncology. 2026;17(6). doi:10.5306/wjco.119908

BibTeX
@article{Gonzlez2026,
  author = {González, Sara Cristina and Ramirez, Carmen Aida and Holgado, Esther and Couñago, Felipe},
  title = {From simple body mass index to lifesaving action: Linking low muscle mass, late diagnosis, and survival in chemoradiotherapy-treated esophageal cancer},
  journal = {World Journal of Clinical Oncology},
  year = {2026},
  volume = {17},
  number = {6},
  doi = {10.5306/wjco.119908}
}
Kostenlos starten →